This triple mechanism distinguishes it from dual-agonist peptides like tirzepatide (GLP-1/GIP) and single-agonist compounds like semaglutide (GLP-1 only), making it the most broadly acting incretin-class compound currently under clinical investigation
Liraglutide injection is contraindicated in patients who have had a serious hypersensitivity reaction to liraglutide or any of the excipients in liraglutide injection [see Contraindications (4)]
PPC does not represent its materials as the investigational drug used in those trials
The most common side effects are [2, 3, 4]: Gastrointestinal side effects, like nausea, vomiting, diarrhoea, constipation, indigestion or heartburn Decreased appetite and/or thirstmake sure you drink plenty of water to stay hydrated and eat nutritious, balanced meals
Needed a Stronger Option Tirzepatide worked well for my blood sugar and helped me lose 28 pounds in the first six months, but then my progress slowed dramatically
Calculation errors here directly affect your results and side effect profile
